5 results match your criteria: "Cairo Medical School.[Affiliation]"

Dapagliflozin improves cardiovascular risk factors in Emirati patients with T2DM.

Ther Adv Endocrinol Metab

March 2021

Assistant Professor of Clinical Pathology, Cairo Medical School, Kasr Al-Ainy, Egypt; Specialist Clinical Pathologist, Zulekha Hospital, Sharjah, UAE.

Background: Dapagliflozin is a sodium-glucose co transporter-2 inhibitor that proved efficacy in reduction of blood glucose level through extrusion of glucose in urine. It is used in treatment of type 2 diabetes mellitus (T2DM). It also has reported cardiovascular and renal benefits in patients with T2DM.

View Article and Find Full Text PDF

Background: In Egypt, the population of older adults is rapidly growing. The last census in 2017 indicated that older adults numbered 94.8 million, which is a 2.

View Article and Find Full Text PDF

Hepatic fibrosis is a common pathway leading to liver cirrhosis, which is the end result of any injury to the liver. Accurate assessment of the degree of fibrosis is important clinically, especially when treatments aimed at reversing fibrosis are being evolved. Despite the fact that liver biopsy (LB) has been considered the "gold standard" of assessment of hepatic fibrosis, LB is not favored by patients or physicians owing to its invasiveness, limitations, sampling errors, etc.

View Article and Find Full Text PDF